Mental health comorbidity in low-income and middle-income countries: a call for improved measurement and treatment
Lancet Psychiatry
.
2018 Nov;5(11):864-866.
doi: 10.1016/S2215-0366(18)30301-8.
Epub 2018 Aug 30.
Authors
Jeremy C Kane
1
,
Michael J Vinikoor
2
,
Emily E Haroz
3
,
Maytham Al-Yasiri
4
,
Sergiy Bogdanov
5
,
John Mayeya
6
,
Francis Simenda
7
,
Laura K Murray
3
Affiliations
1
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: jkane29@jhu.edu.
2
University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294, USA.
3
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
4
Babylon University College of Medicine, Al-illah, Babylon, Iraq.
5
Centre for Mental Health and Psychosocial Support, National University of Kyiv-Mohyla Academy, Kyiv, Ukraine.
6
Ministry of Health, Lusaka, Zambia.
7
Chainama Hospital, Great East Road, Lusaka, Zambia.
PMID:
30174288
PMCID:
PMC6644038
DOI:
10.1016/S2215-0366(18)30301-8
No abstract available
MeSH terms
Comorbidity*
Developing Countries
Humans
Income
Mental Disorders / epidemiology*
Mental Disorders / therapy*
Poverty
Substance-Related Disorders / epidemiology*
Substance-Related Disorders / therapy*
Grants and funding
R01 MH115495/MH/NIMH NIH HHS/United States
U01 MH115495/MH/NIMH NIH HHS/United States
R01 HD070720/HD/NICHD NIH HHS/United States
T32 MH103210/MH/NIMH NIH HHS/United States
K01 MH116335/MH/NIMH NIH HHS/United States